240 related articles for article (PubMed ID: 12018389)
41. Differential effects of tumor necrosis factor-alpha and CD40L on NF-kappa B inhibitory proteins I kappa B alpha, beta and epsilon and on the induction of the Jun amino-terminal kinase pathway in Ramos Burkitt lymphoma cells.
Laskov R; Berger N; Horwitz MS
Eur Cytokine Netw; 2005 Dec; 16(4):267-76. PubMed ID: 16464740
[TBL] [Abstract][Full Text] [Related]
42. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
[TBL] [Abstract][Full Text] [Related]
43. NF-κB pathway mediates vascular smooth muscle response to nicotine.
Wang Z; Wu W; Tang M; Zhou Y; Wang L; Xu W; Qiao Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):375-83. PubMed ID: 23142498
[TBL] [Abstract][Full Text] [Related]
44. Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice.
Willecke F; Tiwari S; Rupprecht B; Wolf D; Hergeth S; Hoppe N; Dufner B; Schulte L; Anto Michel N; Bukosza N; Marchini T; Jäckel M; Stachon P; Hilgendorf I; Zeschky K; Schleicher R; Langer HF; von Zur Muhlen C; Bode C; Peter K; Zirlik A
Thromb Haemost; 2014 Aug; 112(2):379-89. PubMed ID: 24652469
[TBL] [Abstract][Full Text] [Related]
45. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
Schauer SL; Wang Z; Sonenshein GE; Rothstein TL
J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159
[TBL] [Abstract][Full Text] [Related]
46. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.
Campbell M; Trimble ER
Circ Res; 2005 Feb; 96(2):197-206. PubMed ID: 15591231
[TBL] [Abstract][Full Text] [Related]
47. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
Varo N; Libby P; Nuzzo R; Italiano J; Doria A; Schönbeck U
Diab Vasc Dis Res; 2005 May; 2(2):81-7. PubMed ID: 16308911
[TBL] [Abstract][Full Text] [Related]
48. Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain.
Kojok K; Mohsen M; El Kadiry AEH; Mourad W; Merhi Y
J Am Heart Assoc; 2020 Feb; 9(3):e013396. PubMed ID: 32009527
[TBL] [Abstract][Full Text] [Related]
49. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.
Mach F; Schönbeck U; Sukhova GK; Bourcier T; Bonnefoy JY; Pober JS; Libby P
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1931-6. PubMed ID: 9050882
[TBL] [Abstract][Full Text] [Related]
50. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
[TBL] [Abstract][Full Text] [Related]
51. Membrane-Bound CD40L Promotes Senescence and Initiates Senescence-Associated Secretory Phenotype via NF-κB Activation in Lung Adenocarcinoma.
Xu W; Li Y; Yuan WW; Yin Y; Song WW; Wang Y; Huang QQ; Zhao WH; Wu JQ
Cell Physiol Biochem; 2018; 48(4):1793-1803. PubMed ID: 30078020
[TBL] [Abstract][Full Text] [Related]
52. Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway.
Wang XL; Zhou YL; Sun W; Li L
PLoS One; 2016; 11(4):e0153919. PubMed ID: 27120457
[TBL] [Abstract][Full Text] [Related]
53. CD40L induces inflammation and adipogenesis in adipose cells--a potential link between metabolic and cardiovascular disease.
Missiou A; Wolf D; Platzer I; Ernst S; Walter C; Rudolf P; Zirlik K; Köstlin N; Willecke FK; Münkel C; Schönbeck U; Libby P; Bode C; Varo N; Zirlik A
Thromb Haemost; 2010 Apr; 103(4):788-96. PubMed ID: 20174757
[TBL] [Abstract][Full Text] [Related]
54. Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells.
Rauch BH; Millette E; Kenagy RD; Daum G; Fischer JW; Clowes AW
J Biol Chem; 2005 Apr; 280(17):17507-11. PubMed ID: 15731100
[TBL] [Abstract][Full Text] [Related]
55. Soluble CD40 ligand stimulates the pro-angiogenic function of peripheral blood angiogenic outgrowth cells via increased release of matrix metalloproteinase-9.
Bou Khzam L; Boulahya R; Abou-Saleh H; Hachem A; Zaid Y; Merhi Y
PLoS One; 2013; 8(12):e84289. PubMed ID: 24358353
[TBL] [Abstract][Full Text] [Related]
56. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways.
Wang CC; Gurevich I; Draznin B
Diabetes; 2003 Oct; 52(10):2562-9. PubMed ID: 14514641
[TBL] [Abstract][Full Text] [Related]
57. Effect of nuclear factor-kappa B on vascular endothelial growth factor mRNA expression of human pulmonary artery smooth muscle cells in hypoxia.
Zhang H; Xu Y; Zhang Z; Xu S; Ni W; Chen S
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):9-12, 18. PubMed ID: 15165104
[TBL] [Abstract][Full Text] [Related]
58. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
[TBL] [Abstract][Full Text] [Related]
59. [High level expression of recombinant human sCD40L-IZ and identification of its biological activation].
Zhou X; Yu JF; Xu Y; Qi CJ; Huang Y; Wang Y; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):726-9. PubMed ID: 17077011
[TBL] [Abstract][Full Text] [Related]
60. CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling.
Léveillé C; Bouillon M; Guo W; Bolduc J; Sharif-Askari E; El-Fakhry Y; Reyes-Moreno C; Lapointe R; Merhi Y; Wilkins JA; Mourad W
J Biol Chem; 2007 Feb; 282(8):5143-51. PubMed ID: 17182621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
